Related Experiment Video
Updated: Aug 6, 2026
07:33
Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Biological and clinical developments in melanoma vaccines
M Marchand1, V Brichard, N van Baren
1Ludwig Institute for Cancer Research, Brussels Branch, Avenue Hippocrate 74, BP 7459, B-1200 Brussels, Belgium. marie.marchand@bru.licr.org
Expert Opinion on Biological Therapy
|December 1, 2001
Summary
Therapeutic cancer vaccines targeting specific tumor antigens show promise, with some melanoma patients experiencing complete and lasting tumor regressions in early trials. Future research focuses on enhancing immune response, monitoring efficacy, and understanding immune evasion for improved melanoma treatment.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- Defined tumor antigens recognized by autologous T-lymphocytes enable therapeutic vaccination strategies.
- Current therapeutic vaccines are administered to patients with existing, detectable disease.
Purpose of the Study:
- To review the progress and challenges in therapeutic cancer vaccines for melanoma.
- To highlight the importance of robust immune responses and monitoring for vaccine efficacy.
Main Methods:
- Phase I/II clinical trials involving defined tumor antigens.
- Observational studies of patient responses to therapeutic vaccination.
Main Results:
- Tumor regressions, some complete and durable, observed in a subset of melanoma patients.
- Early trials indicate potential for therapeutic vaccination in melanoma treatment.
Conclusions:
- Improving therapeutic vaccine efficacy requires enhancing immune response, developing monitoring methods, and understanding tumor immune evasion.
- Large-scale Phase III trials are necessary to establish the impact of these vaccines on melanoma treatment outcomes.
Related Concept Videos
01:51Vaccinations
Overview
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.